Nucleic Acid Therapeutics
Journal Title
- Nucleic Acid Therapeutics
ISSN
- E 2159-3345 | P 2159-3337 | 2159-3345 | 2159-3337
Publisher
- Mary Ann Liebert Inc.
- Mary Ann Liebert
Listed on(Coverage)
| JCR | 2011-2019 |
|---|---|
| SJR | 1999-2019 |
| CiteScore | 2012-2019 |
| SCI | 2011-2019 |
| SCIE | 2011-2021 |
| CC | 2016-2021 |
| SCOPUS | 2017-2020 |
| MEDLINE | 2016-2021 |
| EMBASE | 2016-2020 |
Active
- Active
based on the information
- SCOPUS:2020-10
Country
- USA
Aime & Scopes
- Nucleic Acid Therapeutics is the leading journal in its field focusing on cutting-edge basic research, therapeutic applications, and drug development using nucleic acids or related compounds to alter gene expression. The Journal examines many new approaches for using nucleic acids as therapeutic agents or in modifying nucleic acids for therapeutic purposes including: oligonucleotides, gene modification, aptamers, RNA nanoparticles, and ribozymes. Nucleic Acid Therapeutics coverage includes: /// RNAi: siRNAs, shRNAs, and miRNAs /// Antisense applications; nucleoside and nucleotide analogs and modifications /// Peptide nucleic acids /// DNA-modified gene therapy /// Nucleic acid-based nanoparticles /// Ethical, legal, and regulatory issues